James Warner - Dec 14, 2022 Form 4 Insider Report for Criteo S.A. (CRTO)

Role
Director
Signature
Ryan Damon, as attorney-in-fact for James Warner
Stock symbol
CRTO
Transactions as of
Dec 14, 2022
Transactions value $
-$477,666
Form type
4
Date filed
12/15/2022, 03:16 PM
Previous filing
Nov 17, 2022
Next filing
Nov 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRTO Ordinary Shares Options Exercise $210K +20.4K +74.04% $10.29 48K Dec 14, 2022 Direct F1, F2, F3
transaction CRTO Ordinary Shares Sale -$528K -20.4K -42.54% $25.90 27.6K Dec 14, 2022 Direct F1, F3, F4
transaction CRTO Ordinary Shares Options Exercise $105K +10.2K +37.02% $10.29 37.8K Dec 14, 2022 Direct F1, F2, F3
transaction CRTO Ordinary Shares Sale -$264K -10.2K -27.02% $25.90 27.6K Dec 14, 2022 Direct F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRTO Non-employee Warrant (right to buy) Options Exercise $0 -20.4K -100% $0.00* 0 Dec 14, 2022 Ordinary Shares 20.4K $10.29 Direct F1, F2, F3, F5
transaction CRTO Non-employee Warrant (right to buy) Options Exercise $0 -10.2K -100% $0.00* 0 Dec 14, 2022 Ordinary Shares 10.2K $10.29 Direct F1, F2, F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 The exercise price of the non-employee warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $10.29 using the exchange rate as of December 14, 2022 (1.00 = $1.06587).
F3 For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
F4 The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.94 to $25.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 Warrant granted on February 7, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on February 7, 2023.
F6 Warrant granted on March 6, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on March 6, 2023.